SCHEMBL2471982

SCHEMBL2471982

O=C(NCc1ccc(Oc2ccccc2)cc1)c1ccc(CN(C(=O)c2ccccc2)c2ccc(O)c(C(=O)O)c2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 8/20 0.74
PDK1 Q15118 2/20 0.57
HPGD P15428 1/20 0.52
MAPK14 Q16539 5/20 0.52
LMNA P02545 1/20 0.49
CYP3A4 P08684 1/20 0.49
HTT P42858 1/20 0.49
MMP13 P45452 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
ERCC1 P07992 1/20 0.48
ERCC4 Q92889 1/20 0.48
PTGES O14684 1/20 0.48
ALOX5 P09917 1/20 0.48
EPHX2 P34913 1/20 0.46
PPARG P37231 1/20 0.46
PPARA Q07869 1/20 0.46
MEN1 O00255 1/20 0.45
CRHBP P24387 1/20 0.45
KMT2A Q03164 1/20 0.45
CRHR2 Q13324 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2468218 0.93 STAT3 (0.67) STAT3PDK1HPGDMAPK14LMNA
SCHEMBL2468968 0.92 STAT3 (0.66) STAT3PDK1HPGDMAPK14LMNA
SCHEMBL2469679 0.91 STAT3 (0.64) STAT3PDK1HPGDMAPK14LMNA
SCHEMBL2469071 0.88 STAT3 (0.60) STAT3PDK1HPGDMAPK14LMNA
SCHEMBL17076869 0.88 STAT3 (0.86) STAT3PDK1PTGESALOX5
SCHEMBL2470433 0.87 STAT3 (0.59) STAT3PDK1HPGDMAPK14LMNA
SCHEMBL2472685 0.87 STAT3 (0.59) STAT3PDK1HPGDMAPK14LMNA
SCHEMBL2468720 0.87 STAT3 (0.58) STAT3PDK1HPGDMAPK14LMNA
SCHEMBL2467356 0.86 STAT3 (0.56) STAT3PDK1HPGDMAPK14LMNA
SCHEMBL2470920 0.86 STAT3 (0.57) STAT3PDK1HPGDMAPK14LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365225-B2 Aryl dicarboxamides LABORATOIRES SERONO SA (CH) 2008-04-29 US claimed
US-20060189583-A1 Aryl dicarboxamides MERCK SERONO SA (CH) 2006-08-24 US claimed
EP-1656139-B1 ARYL DICARBOXAMIDES MERCK SERONO SA (CH) 2011-10-05 EP disclosed
US-7365225-B2 Aryl dicarboxamides LABORATOIRES SERONO SA (CH) 2008-04-29 US disclosed
US-7365225-B2 Aryl dicarboxamides LABORATOIRES SERONO SA (CH) 2008-04-29 US disclosed
US-7365225-B2 Aryl dicarboxamides LABORATOIRES SERONO SA (CH) 2008-04-29 US disclosed
US-20060189583-A1 Aryl dicarboxamides MERCK SERONO SA (CH) 2006-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189583-A1 Aryl dicarboxamides GPR119, PTPRS, ECHS1 STAT3 3402/4885PDK1 78/4885HPGD 2888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.